Letter: biological drugs for inducing remission in ulcerative colitis - authors' reply

被引：0
|
作者：
Stidham, R. W. [1 ]
Lee, T. C. H. [2 ]
Higgins, P. D. R. [1 ]
Deshpande, A. R. [3 ]
Sussman, D. A. [3 ]
Singal, A. G. [4 ]
Elmunzer, B. J. [1 ]
Saini, S. D. [1 ,5 ]
Vijan, S. [2 ,5 ]
Waljee, A. K. [1 ,5 ]
机构：
[1] Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Dept Internal Med, Ann Arbor, MI USA
[2] Univ Michigan, Ann Arbor, MI USA
[3] Univ Miami Miller Sch Med, Miami, FL USA
[4] UT SW Med Ctr, Dallas, TX USA
[5] Ann Arbor Vet Affairs Healthcare Syst, Ann Arbor, MI USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 10期
关键词：
D O I：
10.1111/apt.12724
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1244 / 1244
页数：1
相关论文
共 50 条
  • [1] Letter: biological drugs for inducing remission in ulcerative colitis
    Kaukinen, K.
    Daugherty, P. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1242 - 1244
  • [2] Letter: comparative efficacy of biological therapy in patients with ulcerative colitis - authors' reply
    Stidham, R. W.
    Lee, T. C. H.
    Higgins, P. D. R.
    Deshpande, A. R.
    Sussman, D. A.
    Singal, A. G.
    Elmunzer, B. J.
    Vijan, S.
    Saini, S. D.
    Waljee, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (12) : 1433 - 1434
  • [3] Letter: persisting clinical symptoms in microscopic colitis in remission - authors' reply
    Nyhlin, N.
    Wickbom, A.
    Montgomery, S. M.
    Tysk, C.
    Bohr, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (01) : 118 - 118
  • [4] Letter: mucosal PCR for cytomegalovirus in refractory ulcerative colitis - authors' reply
    Chaparro, M.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 812 - 812
  • [5] Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply
    Yamamoto, T.
    Shimoyama, T.
    Umegae, S.
    Matsumoto, K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) : 1243 - 1243
  • [6] Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply
    Croft, A.
    Walsh, A.
    Doecke, J.
    Radford-Smith, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (08) : 993 - 993
  • [7] Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply
    Casteele, N. Vande
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (01) : 82 - 82
  • [8] Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
    Lenfant, Matthias
    Verstockt, Bram
    Sabino, Joao
    Vermeire, Severine
    Ferrante, Marc
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (05) : 723 - 724
  • [9] Letter: factors that may predict response to ciclosporin in ulcerative colitis - authors' reply
    Katsuno, T.
    Saito, K.
    Yokosuka, O.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (06) : 655 - 655
  • [10] Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply
    Jairath, V.
    Casteele, N. V.
    Hindryckx, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) : 1170 - 1171
12345